Compare with MARKSANS PHARMA. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ANG LIFESCIENCES INDIA vs MARKSANS PHARMA. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ANG LIFESCIENCES INDIA MARKSANS PHARMA. ANG LIFESCIENCES INDIA/
MARKSANS PHARMA.
 
P/E (TTM) x - 9.8 - View Chart
P/BV x 8.6 2.7 317.0% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ANG LIFESCIENCES INDIA   MARKSANS PHARMA.
EQUITY SHARE DATA
    ANG LIFESCIENCES INDIA
Mar-21
MARKSANS PHARMA.
Mar-21
ANG LIFESCIENCES INDIA/
MARKSANS PHARMA.
5-Yr Chart
Click to enlarge
High Rs4666 68.9%   
Low Rs1313 102.2%   
Sales per share (Unadj.) Rs298.033.6 886.4%  
Earnings per share (Unadj.) Rs13.65.8 232.8%  
Cash flow per share (Unadj.) Rs16.16.7 240.0%  
Dividends per share (Unadj.) Rs00.25 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs80.321.7 370.6%  
Shares outstanding (eoy) m5.18409.31 1.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.11.2 8.4%   
Avg P/E ratio x2.26.8 32.0%  
P/CF ratio (eoy) x1.85.9 31.0%  
Price / Book Value ratio x0.41.8 20.1%  
Dividend payout %04.3 0.0%   
Avg Mkt Cap Rs m15216,188 0.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1281,973 6.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,54413,762 11.2%  
Other income Rs m667 8.3%   
Total revenues Rs m1,54913,829 11.2%   
Gross profit Rs m1463,396 4.3%  
Depreciation Rs m13362 3.6%   
Interest Rs m3780 46.5%   
Profit before tax Rs m1013,022 3.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m31636 4.9%   
Profit after tax Rs m702,385 2.9%  
Gross profit margin %9.524.7 38.4%  
Effective tax rate %30.721.1 145.7%   
Net profit margin %4.617.3 26.3%  
BALANCE SHEET DATA
Current assets Rs m1,1599,023 12.8%   
Current liabilities Rs m9162,984 30.7%   
Net working cap to sales %15.743.9 35.9%  
Current ratio x1.33.0 41.9%  
Inventory Days Days91 790.1%  
Debtors Days Days138,887,47571,977,516 193.0%  
Net fixed assets Rs m2783,252 8.5%   
Share capital Rs m52409 12.7%   
"Free" reserves Rs m3648,456 4.3%   
Net worth Rs m4168,865 4.7%   
Long term debt Rs m700-   
Total assets Rs m1,43712,275 11.7%  
Interest coverage x3.738.8 9.6%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.11.1 95.9%   
Return on assets %7.520.1 37.2%  
Return on equity %16.926.9 62.8%  
Return on capital %28.535.0 81.4%  
Exports to sales %00-   
Imports to sales %07.4 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA1,014 0.0%   
Fx inflow Rs m985,874 1.7%   
Fx outflow Rs m11,014 0.1%   
Net fx Rs m974,860 2.0%   
CASH FLOW
From Operations Rs m911,787 5.1%  
From Investments Rs m-77-449 17.1%  
From Financial Activity Rs m-12-153 7.8%  
Net Cashflow Rs m31,186 0.2%  

Share Holding

Indian Promoters % 71.1 48.3 147.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.0 -  
FIIs % 0.0 2.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 28.9 51.8 55.9%  
Shareholders   2,522 214,998 1.2%  
Pledged promoter(s) holding % 42.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ANG LIFESCIENCES INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

MARKSANS PHARMA. 2020-21 Annual Report Analysis (Annual Result Update)

Nov 9, 2021 | Updated on Nov 9, 2021

Here's an analysis of the annual report of MARKSANS PHARMA. for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of MARKSANS PHARMA.. Also includes updates on the valuation of MARKSANS PHARMA..

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ANG LIFESCIENCES INDIA SHARE PRICE


Jan 21, 2022 (Close)

TRACK ANG LIFESCIENCES INDIA

  • Track your investment in ANG LIFESCIENCES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ANG LIFESCIENCES INDIA

ANG LIFESCIENCES INDIA 5-YR ANALYSIS

COMPARE ANG LIFESCIENCES INDIA WITH

MARKET STATS